期刊文献+

HPLC-MS/MS法测定人血浆中烟酸及其代谢物 被引量:2

Determination of Nicacid and Its Metabolites in Human Plasma by HPLC-MS/MS
原文传递
导出
摘要 目的建立人血浆中烟酸及其代谢物的高效液相色谱-质谱联用(HPLC-MS/MS)测定法。方法血浆样品加乙腈沉淀蛋白,取上清液挥干,用流动相溶解,二氯甲烷反洗后进样分析。使用Genimi C18柱(50×3.00mm,3μm),柱温35℃,流动相为0.1%乙酸水溶液;甲醇:异丙醇(98:1:1),流速为0.2mL/min,以正离子MRM模式检测,烟酸、烟酰胺、烟脲酸和内标6-甲基烟酸的检测离子对质荷比(m/z)分别为124.1→80.0、123.1→80.0、181.1→135.0和138.1→92.0。结果烟酸线性范围为1.25→320μg/L,烟酰胺和烟脲酸线性范围均为1.25→1280μg/L,最低检测限均为1.25μg/L,日内和日间RSD均小于9%,方法回收率为89%~105%。结论该法具有快速、灵敏、准确、简便等特点,适用于人血浆烟酸浓度测定及药代动力学和生物利用度研究。 Objective To develop a sensitive HPLC-MS/MS method for the determination of nicacid and its metabolites in human plasma. Methods The assay was conducted with an API 3000 LC-MS/MS system comprising of a Genimi C18 column (50 × 3.00 mm, 3 μm), and an eluate of 0. 10% acetic acid-methanol-isopropyl alcohol (98 1 : 1), and flow rate was 0.2 mL/min. Acetonitrile was used to precipitate protein from the plasma samples. The loading samples contained the residue from the supernatant that were dissolved ix/the eluate solution and rinsed by diehloromethane was used as the loading samples. The ion pairs of m/z 124. 1→80. 0, m/z 123. →80. 0, m/z 181.1→135.0 and m/z 138. 1→92.0 were used to quantify nicaeid, niacinamide, nicotinuric acid and 6-methyl nicotinic acid (IS), respectively. Results The standard curves of nicacid, niacinamide and nieotinuric were linear in the range of 1.25-320 μg/L,1.25-1280 μg/L and 1.25-1280μg/L, respectivly. All with a low determination limits of 1.25 μg/L and a less than 9% within-day and inter-day RSD. The recovery rates reached 89% to 105%. Conclsuion The method is simple, rapid, sensitive, and suitable for the determination of nicaeid and its metabolites in human plasma.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2010年第6期1051-1054,共4页 Journal of Sichuan University(Medical Sciences)
关键词 HPLC-MS/MS 烟酸 代谢物 烟脲酸 烟酰胺 血药浓度 HPLC-MS/MS Nieaeid Metabolites Nicotinuric acid Niacinamide Plasma concentration
  • 相关文献

参考文献4

二级参考文献8

  • 1Hemgen N, Serberthn V, Hengen M. High-performance liquid chromatographic determination of free nicotinic and its metabolite acid in plasma and urine [J]. Clin Chem, 1978,24(10):1 740 - 1 743.
  • 2Ding RW, Kolbe K, Merz B, et al. Pharmacokinetics of nicotinic acid-salicylic acid interaction [ J]. Clin Pharmacol Ther, 1989,46(6) :642-647.
  • 3陈修.心血管药理学[M].北京:人民卫生出版社,1997.514.
  • 4Stein J,Hahn A,Rehner G.High-performance liquid-chromatographic determination of nicotinic acid and nicotinamide in biological samples applying post-column derivatization resulting in bathmochrome absorption shifts [J].J Chromatography B,1995;665:71-78.
  • 5Nikolaus H,Volker S,Michaela H.High-performance liquidchromatographic determination of free nicotinic acid and its metabolite,nicotinuric acid,in plasma and urine [J].Clin Chem,1978; 24:1740-1743.
  • 6Neuvonen PJ,Roivas L,Laine K,et al.The bioavailability of sustained release nicotinic acid formulations [J].Clin Pharmacol,1991 ;32:473-476.
  • 7Carlson LA.Determination of free nicotinic acid in blood plasma [J].Clin Chim Acta,1966;13:349-351.
  • 8邓立东,陈钧,杨俊毅,贾运涛,周静,蒋学华.烟酸缓释片在体外释放和体内吸收的相关性研究[J].华西药学杂志,2002,17(1):26-27. 被引量:10

共引文献12

同被引文献18

  • 1范新华,屠永锐,胡一桥.自制复方洛伐他汀-烟酸缓释片及其人体药动学研究[J].世界临床药物,2009,30(12):739-745. 被引量:3
  • 2王萍,顾世芬,杨德隆,吴贵宝,李铃,陈汇.烟酸缓释片的人体药代动力学及相对生物利用度[J].中国药师,2005,8(2):94-96. 被引量:7
  • 3李祎.烟酸缓释胶囊家犬体内药动学及相对生物利用度研究[J].现代食品与药品杂志,2006,16(5):30-32. 被引量:1
  • 4Pfuhl P,Karcher U,Haringa N. Simultaneous determination of niacin,niacinamide and nicotinuric acid in human plasma[J].Journal of Pharmaceutical and Biomedical Analysis,2005,(02):1045-1052.
  • 5Christopher SV,Ramadan AH,Sameer HN. Revisiting niacin:reviewing the evidence[J].Journal of Clinical lipidology,2007,(04):248-255.
  • 6Abbott Laboratories. Advicor" (niacin extended-release/lovastatin tablets) [EB/OL]. [2014-07-01]. http://www.advicor.com/important- safety-information.asp.
  • 7Pfuhl P, K~ircher U, H~iring N, et al. Simultaneous determination of niacin, niacinamide and nicotinuric acid in human plasma[J]. ] Pharm Biomed Anal, 2005, 36(5): 1045-1052.
  • 8Lauring B, Rosko K, Luo WL, et al. A comparison of the pharmacokinetics of two different formulations of extended-release niacin[J]. Curt Med Res Opin, 2009, 25(1): 15-22.
  • 9Zhang P, Sun Y, Shi G, et al. Quantification of niacin and its metabolite nicotinuric acid in human plasma by LC-MS/MS:application to a clinical trial of a fixed dose combination tablet of niacin extended-release/simvastatin (500 mg/10 mg) in healthy Chinese volunteers[]]. Int ] Anal Chem, 2015: 212437.
  • 10Liu M, Zhang D, Wang X, et al. Simultaneous quantification of niacin and its three main metabolites in human plasma by LC- MS/MS[I]. ] Chromatogr B Analyt Technol Biomed Life Sci, 2012, 904(2): 107-114,.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部